Elyse Stock
Overview
Elyse Stock received $2M in total compensation, including $378K in salary, at Biohaven Pharmaceutical Holding Co Ltd. in 2019.
Source: SEC filing on March 20, 2020.
Related executives
We found six more executives who work or worked at Biohaven Pharmaceutical Holding Co Ltd..
Vlad Coric
Biohaven Pharmaceutical Holding Co Ltd.
Chief Executive Officer
William Jones
Biohaven Pharmaceutical Holding Co Ltd.
Chief Commercial Officer of Migraine & Common Diseases
Kimberly Gentile
Biohaven Pharmaceutical Holding Co Ltd.
Senior Vice President, Clinical Operations
James Engelhart
Biohaven Pharmaceutical Holding Co Ltd.
Chief Financial Officer
Charles Conway
Biohaven Pharmaceutical Holding Co Ltd.
Chief Scientific Officer
John Tilton
Biohaven Pharmaceutical Holding Co Ltd.